热门资讯> 正文

Protalix BioTherapeutics第二季度盈利预览

2026-08-11 23:10

Protalix Biotherapeutics, Inc.(PLX) 0

Protalix BioTherapeutics (PLX) is scheduled to announce Q2 earnings results on Wednesday, August 12th, before market open.
The consensus EPS estimate is -$0.01, and the consensus revenue estimate is $12.93M (-17.4% Y/Y).
Over the last 1 year, PLX has beaten EPS estimates 50% of the time and has beaten revenue estimates 100% of the time.

More on Protalix BioTherapeutics

Protalix BioTherapeutics, Inc. (PLX) Q1 2026 Earnings Call Transcript
Protalix reaffirms $78M-$83M 2026 revenue outlook following $25M Elfabrio milestone
Seeking Alpha’s Quant Rating on Protalix BioTherapeutics
Historical earnings data for Protalix BioTherapeutics
Financial information for Protalix BioTherapeutics

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。